JPMorgan Chase & Co’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.92K | Sell |
5,340
-74,389
| -93% | -$54.6K | ﹤0.01% | 5563 |
|
|
2025
Q1 | $79.7K | Sell |
79,729
-1,319,988
| -94% | -$1.32M | ﹤0.01% | 4837 |
|
|
2024
Q4 | $14.8M | Buy |
1,399,717
+1,335,296
| +2,073% | +$14.2M | ﹤0.01% | 1953 |
|
|
2024
Q3 | $851K | Buy |
64,421
+1,629
| +3% | +$21.5K | ﹤0.01% | 3735 |
|
|
2024
Q2 | $617K | Buy |
62,792
+28,081
| +81% | +$276K | ﹤0.01% | 3749 |
|
|
2024
Q1 | $477K | Sell |
34,711
-26,406
| -43% | -$363K | ﹤0.01% | 3983 |
|
|
2023
Q4 | $1.04M | Buy |
+61,117
| New | +$1.04M | ﹤0.01% | 3512 |
|